The SEC is shifting emphasis toward core enforcement priorities after Paul Atkins took over as chair in early 2025, with David Woodcock leading a new enforcement task force focused on financial reporting, auditing, and accounting accuracy. Panel experts described the approach as a return to the fundamental internal controls and accounting oversight model of the early 2000s. The report also discussed how proposed changes to Regulation S-K risk factors and executive compensation disclosure regimes could influence enforcement burden and what is treated as material to investors. Enforcement effort on immaterial compensation line-item questions was cited as an area needing reform. For public biotech companies, the update signals a renewed focus on reporting fundamentals and audit-related compliance, affecting how management prioritizes controls and how risk disclosures are documented for scrutiny.